Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function
Sidharth P. Mishra, … , Sushil G. Rane, Hariom Yadav
Sidharth P. Mishra, … , Sushil G. Rane, Hariom Yadav
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e168443. https://doi.org/10.1172/jci.insight.168443.
View: Text | PDF
Research Article Aging Microbiology

Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function

  • Text
  • PDF
Abstract

Aging-related abnormalities in gut microbiota are associated with cognitive decline, depression, and anxiety, but underlying mechanisms remain unstudied. Here, our study demonstrated that transplanting old gut microbiota to young mice induced inflammation in the gut and brain coupled with cognitive decline, depression, and anxiety. We observed diminished mucin formation and increased gut permeability (“leaky gut”) with a reduction in beneficial metabolites like butyrate because of decline in butyrate-producing bacteria in the aged gut microbiota. This led to suppressed expression of butyrate receptors, free fatty acid receptors 2 and 3 (FFAR2/3). Administering butyrate alleviated inflammation, restored mucin expression and gut barriers, and corrected brain dysfunction. Furthermore, young mice with intestine-specific loss of FFAR2/3 exhibited gut and brain abnormalities akin to those in older mice. Our results demonstrate that reduced butyrate-producing bacteria in aged gut microbiota result in low butyrate levels and reduced FFAR2/3 signaling, leading to suppressed mucin formation that increases gut permeability, inflammation, and brain abnormalities. These findings underscore the significance of butyrate-FFAR2/3 agonism as a potential strategy to mitigate aged gut microbiota–induced detrimental effects on gut and brain health in older adults.

Authors

Sidharth P. Mishra, Shalini Jain, Bo Wang, Shaohua Wang, Brandi C. Miller, Jea Y. Lee, Cesar V. Borlongan, Lin Jiang, Julie Pollak, Subhash Taraphder, Brian T. Layden, Sushil G. Rane, Hariom Yadav

×

Figure 7

FFAR2/3 deficiency in the gut exacerbates early aging in the brain, including neuroinflammation and behavioral changes.

Options: View larger image (or click on image) Download as PowerPoint
FFAR2/3 deficiency in the gut exacerbates early aging in the brain, incl...
(A) The expression of Muc2 in both ileum and colon was significantly lower in the 7-month-old, intestine-specific FFAR2 (iF2) and FFAR3 (iF3) knockout (KO) mice compared with their age- and sex-matched wild-type (WT) controls. (B–E) In line, the gut permeability (FITC-dextran leakage) (B) was higher and the expression of inflammatory genes (Il1b, Il6, and Tnfa) (C–E) was lower in the intestine of the 7-month-old iF2/3 KO mice than in WT controls. (F–M) The brains of the 7-month-old iF2/3-KO mice showed significantly higher levels of inflammatory markers (Il1b, Il6, and Tnfa) (F–H) along with cognitive decline (MWM test) (I), depression (FS and splash tests) (J and K), and anxiety-like behaviors (NC and MB tests) (L and M) compared with WT controls. (A–M) No significant changes in Muc2 expression (A), gut permeability (B), inflammation in the gut (C–E) and brain (F–H), and behavioral changes (I–M) were seen in iF2/3-KO mice compared to WT controls. All the values represent the mean of 5–10 animals in each group, and error bars represent the standard error of means. Statistical significance was determined using ANOVA and/or t test, and P values *P < 0.05, **P < 0.01, and ***P < 0.001 are statistically significant.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts